Home / Combinations / Thymalin + Epithalon
CombinationAnti-AgingRecoveryAnecdotal evidence
Thymalin + Epithalon
Immune-Longevity Protocol
Both Thymalin and Epithalon are short bioregulatory peptides developed by Vladimir Khavinson and studied across decades of Russian gerontological research. Thymalin is associated with thymic peptide function and immune regulation in aging populations; Epithalon with pineal peptide activity, melatonin normalization, and telomere elongation. The combination is commonly referenced in longevity research for its dual immune-modulating and anti-aging mechanistic rationale.
Stack components
ThymalinCompound 01
EpithalonCompound 02
2
Compounds
2
Sources on file
2
Providers carry all
Mechanism
What each compound is researched for on its own. Nothing here describes an interaction between them.
Compound 01
Thymalin
Thymic bioregulatory peptide researched for restoring immune surveillance, T-cell function, and neuroendocrine-immune communication in aging subjects.
Compound 02
Epithalon
Pineal tetrapeptide researched for telomerase activation, melatonin normalization, and extension of healthy lifespan across multiple experimental models.
Composition
2 compounds · 2 research areas
Stated as recorded. This page describes each compound separately and makes no claim that they act together.
Safety notes
Both peptides have multi-decade Russian research records with a favorable safety profile at studied doses. Most available evidence comes from open-label trials and animal studies; controlled human RCT data remains limited compared to Western pharmacological standards.
Author-written. Not derived from any compound field, and not covered by the profile-integrity audit that gates the peptide pages.
Research references2 sources
Moderate
Peptide bioregulators: a new class of geroprotectors. 35 years of research
St. Petersburg: Aster 2009
PeptideBase notePer-component source; Khavinson laboratory — no formal combination RCT exists
no identifier on file
Moderate
Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells
Bull Exp Biol Med 2003
PeptideBase noteEpithalon component study — no combination study exists
no identifier on file
Related combinations3 share an area
Educational use only
PeptideBase documents what compounds are researched together and what evidence exists for each one separately. It does not provide medical advice, diagnosis, treatment, prescribing guidance or dosing instructions. Last reviewed 23 Apr 2026.
PeptideBase documents what compounds are researched together and what evidence exists for each one separately. It does not provide medical advice, diagnosis, treatment, prescribing guidance or dosing instructions. Last reviewed 23 Apr 2026.